Related by context. All words. (Click for frequent words.) 74 colorectal adenoma 72 advanced adenoma 71 distal colon 70 polyp recurrence 69 hormone receptor negative 68 elevated triglyceride levels 68 oesophageal adenocarcinoma 68 gallstone disease 67 advanced adenomas 67 highest quintile 67 coronary calcification 67 colorectal adenomas 67 MetS 67 recurrent VTE 67 highest tertile 66 lobular cancer 66 CVD mortality 66 ductal cancer 66 systolic dysfunction 66 Calcium intake 66 serum lipid levels 66 endometrial hyperplasia 66 prostate cancer CaP 66 serum homocysteine 65 colorectal neoplasia 65 elevated LDL cholesterol 65 nonfasting triglycerides 65 transferrin saturation 65 carotid plaques 65 chronic periodontitis 65 dysglycemia 65 serum triglycerides 65 gastric cardia 65 colorectal polyp 65 metachronous 65 invasive lobular 65 urolithiasis 65 invasive ductal 64 elevated CRP 64 lobular carcinoma 64 CP CPPS 64 BRCA1 mutation carriers 64 N telopeptide 64 esophageal squamous cell carcinoma 64 serum GGT 64 lumbar disk herniation 64 renal cell carcinomas 64 nonmelanoma skin cancers 64 pancreatic prostate 64 liver metastasis 64 recurrent venous thromboembolism 64 atypical hyperplasia 64 HER2 expression 64 isolated systolic hypertension 64 CHD mortality 64 proximal colon 64 thyrotropin levels 64 beta carotene supplementation 64 dietary calcium intake 64 KRAS mutations occur 64 postoperative AF 64 bilateral oophorectomy 64 microbleeds 64 perioperative morbidity 64 #OHD levels 63 ductal breast cancer 63 advanced neoplasia 63 fatal IHD 63 pCR 63 CHD CVD 63 carotid plaque 63 postoperative delirium 63 obstructive coronary artery 63 HNSCC 63 atypical ductal hyperplasia 63 adenoma recurrence 63 nodal metastasis 63 serum phosphate 63 oropharyngeal cancer 63 nonfasting triglyceride levels 63 serum PTH 63 cirrhotic patients 63 hyperhomocysteinemia 63 CC genotype 63 breast endometrial 63 perimenopausal women 63 colorectal cancer incidence 63 latent celiac disease 63 nonvertebral fracture 63 atrophic gastritis 63 plasma homocysteine levels 63 adenoma 63 recurrent UTI 63 diabetes mellitus DM 63 severe periodontitis 63 malignant neoplasm 63 PLX STROKE targeting 63 serum PSA 63 colorectal neoplasms 63 bacteriuria 63 Radical prostatectomy 63 node metastases 63 autonomic dysfunction 63 hyperplastic polyps 63 endometrial carcinoma 63 carotid bruit 63 TT genotype 63 Uterine cancer 63 precursor lesions 63 leiomyomas 63 cerebral infarction 63 Heavy menstrual bleeding 63 uveal melanoma 63 obese postmenopausal 63 mmHg diastolic 63 elevated triglycerides 62 pathologic fractures 62 prostate carcinoma 62 colonic polyps 62 hydroxyvitamin D levels 62 arterial calcification 62 multivariate adjustment 62 locoregional recurrence 62 hypercalciuria 62 selenium intake 62 deep venous thromboses 62 lobular breast cancer 62 subclinical atherosclerosis 62 thiazide diuretics 62 lowest tertile 62 serous ovarian cancer 62 oesophageal cancers 62 squamous cell lung cancer 62 esophageal cancers 62 triglyceride concentrations 62 postoperative mortality 62 LV dysfunction 62 intact parathyroid hormone 62 carotid atherosclerosis 62 #.#mmHg 62 diverticular bleeding 62 Soy isoflavones 62 homocysteine concentrations 62 bowel polyps 62 hypovitaminosis D 62 anovulatory infertility 62 situ LCIS 62 elevated IOP 62 ductal carcinomas 62 Chronic pancreatitis 62 GSTT1 62 folate concentrations 62 elevated uric acid 62 oncogenic HPV 62 TNF blocker therapy 62 Adequate vitamin D 62 precancerous cervical 62 serum uric acid 62 confidence interval #.#-#.# 62 Hip fracture 62 lactate dehydrogenase 62 thromboembolic disease 62 NP CRNs 62 chorioamnionitis 62 PCA3 scores 62 hip BMD 62 impaired endothelial 62 postmenopausal hormone 62 salivary flow 62 serum leptin 62 HIV HCV coinfected 62 premenopausal breast cancer 62 abdominal adiposity 62 colorectum 62 diastolic hypertension 62 subclinical hypothyroidism 62 artery calcification 62 axillary lymph nodes 62 proliferative diabetic retinopathy 62 postoperative morbidity 62 multivariable adjusted 62 inversely associated 62 atherogenic dyslipidemia 62 perioperative mortality 61 impaired glucose metabolism 61 NMIBC 61 intracranial hemorrhage ICH 61 serum vitamin D 61 rebleeding 61 elevated serum creatinine 61 hepatic steatosis 61 mesotheliomas 61 basal cell nevus syndrome 61 microvascular disease 61 genitourinary tract 61 antioxidant supplementation 61 gastric adenocarcinoma 61 elevated ALT 61 nondiabetic patients 61 apolipoprotein E4 61 protein excretion 61 histologic subtype 61 colorectal bowel 61 nephrolithiasis 61 peritoneal carcinomatosis 61 mutated K ras 61 Helicobacter pylori infection 61 overt hepatic encephalopathy HE 61 serum parathyroid hormone 61 breast uterine 61 triacylglycerol concentrations 61 genital herpes infections 61 metastatic gastric 61 glycated hemoglobin levels 61 adenomatous 61 glomerular filtration 61 serum urate 61 haemorrhagic stroke 61 amenorrhoea 61 subclinical hyperthyroidism 61 contralateral breast 61 systolic hypertension 61 elevated hsCRP 61 chronic prostatitis 61 obstructive CAD 61 HbA1C levels 61 histological subtype 61 thyrotropin 61 atheroma volume 61 echocardiographic parameters 61 left ventricular diastolic 61 plasma triglycerides 61 flavonoid intake 61 thrombocytopenic 61 serum selenium 61 prostate carcinogenesis 61 troponin T 61 comorbid illnesses 61 serum calcium 61 nonvertebral fractures 61 familial pancreatic cancer 61 BRCA mutation carriers 61 GSTM1 61 inflammatory rheumatic 61 invasive carcinoma 61 intrahepatic 61 nonmelanoma 61 kg m² 61 venous thrombosis 61 aminotransferase ALT 61 urinary bladder cancer 61 BRCA2 mutation carriers 61 PHPT 61 blood glucose concentrations 61 serum urate levels 61 spontaneous preterm delivery 61 colon rectal 61 contralateral breast cancer 61 tertile 61 benign noncancerous 61 β blockers 61 Nonalcoholic fatty liver 61 abnormal lipid 61 undergone radical prostatectomy 61 arterial stiffening 61 nonmetastatic 61 hepatorenal syndrome 61 colorectal tumor 61 gastric cancers 61 invasive ductal breast cancer 61 colorectal carcinoma 61 primary hyperparathyroidism 61 Papillary 61 metabolic syndrome MetS 60 nonalcoholic steatohepatitis 60 hepatocellular carcinomas 60 metastatic prostate 60 Chlamydia trachomatis infection 60 NSAID associated 60 prostate colon 60 hydroxyvitamin D concentrations 60 mucosal inflammation 60 Adjuvant chemotherapy 60 arterial thromboembolic events 60 lung metastases 60 shorter telomere length 60 recurrent myocardial infarction 60 rs# [002] 60 gastric carcinoma 60 pT3 60 leucopenia 60 aged ≥ 60 IPAH 60 carotid IMT 60 adenocarcinomas 60 elevated LDH 60 gross hematuria 60 hepatic enzymes 60 endometriosis ovarian cysts 60 cardiac troponin T 60 hematopoietic cancers 60 bicuspid aortic valves 60 curative resection 60 carotid stenosis 60 biochemical recurrence 60 urinary oxalate 60 waist circumferences 60 neutrophil counts 60 Insulin sensitivity 60 postoperative atrial fibrillation 60 axillary node 60 tumor histology 60 diastolic BP 60 relapsed MM 60 DRB1 * 60 breast carcinoma 60 hypophosphatemia 60 Squamous 60 clinically detectable 60 distant metastases 60 SGPT 60 lignan intake 60 PSADT 60 arterial thickening 60 adiponectin concentrations 60 MMSE scores 60 cTnT 60 patients undergoing CABG 60 ovarian pancreatic 60 cardiovascular disease hypertension 60 abdominally obese 60 % CI #.#-#.# [007] 60 intracerebral haemorrhage 60 pulmonary dysfunction 60 diffuse gastric 60 femoral neck fracture 60 prostate abnormalities 60 specific antigen PSA 60 vertebral fracture 60 Tumor shrinkage 60 % CI #.#-#.# [008] 60 restenosis reblockage 60 angina chest 60 cervical neoplasia 60 Hazard Ratio HR 60 coronary stenosis 60 cervical lymph node 60 esophagus bladder 60 pulmonary metastasis 60 dietary folate intake 60 albumin excretion rate 60 baseline serum creatinine 60 cervical breast 60 fetal chromosomal 60 lymphatic cancers 60 osteosarcomas 60 NHANES III 60 testicular germ cell 60 hyperphenylalaninemia HPA due 60 Premature menopause 60 total thyroidectomy 60 extracapsular extension 60 nonsmall cell lung cancer 60 venous thromboembolic disease 60 orofacial clefts 60 de ath 60 HBeAg negative 60 Rectal cancer 60 ejection fractions 60 root caries 60 recurrent ovarian 60 macroalbuminuria 60 SLNB 60 telomere lengths 60 serum creatinine levels 60 ABCB1 60 binary restenosis 60 metastatic lymph nodes 60 preserved ejection fraction 60 urinary excretion 60 macrovascular events 60 PON1 activity 60 papillary renal cell carcinoma 60 selenium supplementation 60 plasma selenium 60 plasma folate 60 HER2 amplification 60 esophageal gastric 60 central adiposity 60 hamartomas 60 uterine cancers 60 thromboembolism 60 acute GVHD 60 osteopenic 60 cardiovascular mortality 60 variceal bleeding 60 precancerous tumors 60 SUVmax 60 coagulation abnormalities 59 non fasting triglycerides 59 Folate deficiency 59 octreotide LAR 59 PAOD 59 colon rectum 59 nocturnal hypoglycaemia 59 calcified plaques 59 Fasting blood glucose 59 HGPIN 59 thrombotic complications 59 bioavailable testosterone 59 fasting glucose levels 59 secondary hyperparathyroidism 59 RBP4 levels 59 ALDH2 deficient 59 HER2 positivity 59 colorectal tumors 59 normotensive 59 noncardiac 59 Androgen deprivation therapy 59 thrombo embolic 59 β blocker 59 endometrial ovarian 59 umol L 59 HbA 1c levels 59 hemorrhagic complications 59 fluoroquinolone resistance 59 atypia 59 lipohypertrophy 59 endometrial cancers 59 ovulatory infertility 59 postoperative pulmonary 59 adenocarcinoma histology 59 vitreous floaters 59 bacterial prostatitis 59 pancreas esophagus 59 type2 diabetes 59 alanine aminotransferase ALT 59 HER2 overexpression 59 creatinine ratio 59 BRCA2 mutations 59 DVT PE 59 candidemia 59 H. pylori eradication 59 Endometrial cancer 59 pancreatic lung 59 serum estradiol 59 thyroid nodules 59 circulating estrogens 59 adiponectin levels 59 T1DM 59 untreated celiac disease 59 aminotransferases 59 LRP5 59 Subclinical hypothyroidism 59 colorectal pancreatic 59 metastatic lung cancer 59 transaminase levels 59 reinterventions 59 lung metastasis 59 venous blood clots 59 silent ischemia 59 serum testosterone 59 POAG 59 precancerous polyp 59 seropositivity 59 gynecologic malignancy 59 chronic rhinosinusitis 59 calcium antagonists 59 differentiated thyroid 59 perioperative complications 59 dose ionizing radiation 59 VLDL cholesterol 59 spontaneous bacterial peritonitis 59 anti JCV antibodies 59 chlamydial infection 59 atherosclerotic lesions 59 oral squamous cell 59 Abdominal fat 59 Leydig cell 59 CMV infection 59 Erythropoietic therapies may 59 reinfarction 59 Endometrial 59 bronchoalveolar 59 post thrombotic syndrome 59 nmol l 59 improves insulin sensitivity 59 Preterm infants 59 fetuin 59 locoregional 59 minimally symptomatic 59 aortic stiffness 59 albumin excretion 59 vitamin D inadequacy 59 Processed meat 59 cardiovascular morbidity 59 intracranial atherosclerosis 59 Skin sterol 59 colorectal liver metastases 59 gallstone formation 59 potentially modifiable 59 HbF 59 external genital lesions 59 hypercalcaemia 59 carotid artery intima media 59 salpingo oophorectomy 59 GSTM1 gene 59 Thal Dex 59 pulmonary metastases 59 CI #.#-#.# [002] 59 Genetic variants 59 Infusion Reactions Severe 59 STRIDE PD 59 neurologic complications 59 corticosteroid dose 59 squamous cell cancers 59 testicular tumors 59 cerebral oxygenation 59 diastolic blood pressures 59 colorectal adenocarcinoma 59 coinfection 59 elevated fasting glucose 59 atherosclerotic vascular disease 59 KRAS mutant tumors 59 Colon polyps 59 symptomatic intracranial 59 mucinous 59 antiangiogenic therapy 59 seminal vesicle invasion 59 lipoprotein Lp 59 PSA nadir 59 RYGB surgery 59 serum calcium levels 59 Febrile neutropenia 59 estrogen deficiency 59 Prehypertension 59 urothelial cancer 59 nondiabetic 59 Chlamydia infection 59 fibrin deposition 59 HOMA IR 59 serum BDNF 59 baseline LDH 59 GI bleeds 59 CIN2 + 59 androgen suppression 59 phytoestrogen intake 59 embolic stroke 59 fasting insulin 59 tertiles 59 NNRTI resistance 59 oropharyngeal cancers 59 EUS FNA 59 systolic blood pressures 59 EpCAM expression 59 faulty BRCA genes 59 abnormal lipid levels 59 symptomatic VTE 59 gestational diabetes mellitus 59 PCa 59 c reactive protein 59 underwent surgical resection 59 Postoperative complications 59 genital ulcers 59 intravenous bisphosphonates 59 hemoglobin A1c levels 59 NAFLD 59 undergoing radical prostatectomy 59 gastric varices 59 advanced hepatocellular carcinoma 59 overt nephropathy 59 GH deficiency 59 Homocysteine levels 59 carotid artery blockage 59 GSTP1 59 SNP rs# [002] 59 hemodialysis patients 59 grade squamous intraepithelial 59 MSMB 59 postmenopausal hormones 59 anal HPV 59 EGFR mutation positive 59 abnormal lipids 59 ductal lobular 59 venous thromboembolisms 59 Endothelial function 59 Boffetta 59 atherosclerotic progression 59 VTEs 59 asymptomatic carotid stenosis 59 nonalcoholic steatohepatitis NASH 59 esophageal adenocarcinoma 59 nodal metastases 59 genital HPV infections 58 TCF#L# 58 plasma leptin 58 recurrent coronary 58 bladder cervix 58 paricalcitol 58 lymphocytosis 58 lymphovascular invasion 58 cisplatin chemotherapy 58 intraoperative complications 58 lipid lowering therapy 58 preoperative chemotherapy 58 thyrotoxicosis 58 hereditary predisposition 58 Aortic stenosis 58 adenomatous polyps 58 lobular involution 58 testicular cancers 58 DQB1 * 58 morphometric vertebral fractures 58 malignant polyps 58 thromboembolic complications 58 cervical intraepithelial neoplasia 58 probiotic supplementation 58 APOE e4 58 Elevated CRP 58 kaempferol 58 frequently benign tumor 58 distensibility 58 biochemical relapse 58 conventional angiography 58 male hormones androgens 58 elevated homocysteine 58 CIN3 58 clinically localized prostate 58 progesterone receptor negative 58 esophageal tumors 58 hsCRP levels 58 urate levels 58 ASCUS 58 HIV uninfected 58 oncologic outcomes 58 oral antidiabetic medication 58 insulin resistance syndrome 58 cardioembolic stroke 58 Prostatitis 58 dietary sodium 58 ductal adenocarcinoma 58 angiographically 58 esophageal reflux 58 prednisone prednisolone 58 underwent radical prostatectomy 58 ovarian carcinoma 58 androgen deficiency 58 flow mediated dilation 58 bile duct cancers 58 thromboembolic 58 AML MDS 58 ADPKD 58 renal tumors 58 fibroids endometriosis 58 pharyngeal cancer 58 serum folate concentrations 58 flutamide 58 parous women 58 urinary calcium 58 extracolonic findings 58 hemoglobin A1c HbA1c 58 hypoperfusion 58 subtrochanteric 58 onset diabetes mellitus 58 colon tumors 58 HER2 positive cancers 58 benign breast 58 intestinal permeability 58 prostate cancer PCa 58 neoplasias 58 Breslow thickness 58 axillary node dissection 58 aspartate aminotransferase AST 58 postoperative hemorrhage 58 intravesical therapy 58 cervical carcinoma 58 thrombotic events 58 rs# [004] 58 urothelial carcinoma 58 contrast induced nephropathy 58 endometrial thickness 58 hypercoagulable 58 fasting triglycerides 58 visceral adiposity 58 catheter angiography 58 cerebral microbleeds 58 operable breast cancer 58 completely resected 58 ALT elevation 58 atherothrombosis 58 receiving antiretroviral therapy 58 APOE e4 allele 58 hypothalamic amenorrhea 58 mineral density 58 K ras mutations 58 C. trachomatis 58 folate intake 58 NSTE ACS 58 CARDIA study 58 #.#ng/ml 58 transfusion syndrome 58 LDL cholesterol concentrations 58 colon adenomas 58 de aths 58 uncircumcised males 58 necrotic core 58 TMP SMX 58 % CI #.#-#.# [003] 58 VEGF expression 58 recurrent metastatic 58 GISTs 58 HPV subtypes 58 ovarian hormones 58 dopaminergic therapy 58 definite stent thrombosis 58 aneurysmal subarachnoid hemorrhage 58 neurodevelopmental outcome 58 postoperative infection 58 microvascular complications 58 oesophageal squamous cell carcinoma 58 2D 4D ratio 58 CK # plasma concentrations 58 mIU L 58 endogenous estrogen 58 de novo AML 58 cutaneous melanoma 58 coronary heart 58 nicotine metabolite 58 thromboembolic events 58 SHBG levels 58 Gastric cancer 58 stratifying patients 58 poorer prognosis 58 gestational diabetes mellitus GDM 58 perioperatively 58 trans palmitoleate 58 antigen PSA levels 58 lipid lowering agents 58 tamoxifen Nolvadex ® 58 PBDE chemicals 58 lymph node removal 58 intestinal polyps 58 folic acid deficiency 58 diabetic kidney 58 CIMZIA ™ 58 Barrett mucosa 58 dietary glycemic index 58 subclinical disease 58 T2DM 58 Darapladib 58 Hb A1C 58 NSAID induced GI 58 glycosylated hemoglobin HbA1c 58 PCNSL 58 eosinophil count 58 pancreatic ovarian 58 NAT2 58 amyloid deposition 58 baseline HbA1c 58 histologically confirmed 58 aerodigestive tract 58 loop diuretics 58 CYP#D# inhibitor 58 cytoreductive surgery 58 naturally occurring estrogen 58 dietary folate 58 oesophageal 58 AST ALT 58 ovulatory cycles 58 carotid artery narrowing 58 hypercholesterolaemia 58 benign prostate 58 invasive carcinomas 58 Ischemic heart 58 squamous cell histology 58 periprocedural MI 58 Severe hypoglycemia 58 total cholesterol triglycerides 58 SRBD 58 postmenopausal breast cancer 58 8 OHdG 58 Venous thromboembolism 58 inflammatory polyarthritis 58 vascular reactivity 58 femoral neck BMD 58 genital ulcer disease 58 LV hypertrophy 58 lymph node metastasis 58 CHD coronary 58 distant metastasis 58 microvessel density 58 folate intakes 58 microangiopathy 58 osteoporotic fracture 58 Basal Cell 58 heterozygotes 58 coronary artery calcium 58 tHcy 58 H pylori 58 epithelial tumors 58 NSAID induced 58 endometrial kidney 58 anal cancers 58 abnormal glucose metabolism 58 lichen planus 58 nonproliferative 58 unresectable tumors 58 Vitamin D insufficiency 58 anogenital 58 carcinoids 58 habitual snoring 58 S. aureus infection 58 Diabetic nephropathy 58 LV ejection fraction 58 renal parenchyma 58 hepatocellular carcinoma liver 58 dentinal hypersensitivity 58 estrogen progestin therapy 58 nonischemic 58 Multivariate analyzes 58 GBA mutations 58 osteoid 58 Multivariate analysis 58 limiting generalizability 58 renal cysts 58 magnesium intake 58 #mg/dL [001] 58 CDI recurrence 57 CYT# potent vascular disrupting 57 transaminase elevations 57 symptomatic fibroids 57 HLA DRB1 SE 57 BMPR2 57 Therein lurks 57 tuberculin skin testing 57 kcal d 57 potassium sparing diuretics 57 fragility fracture 57 atopic disorders 57 trophoblast cells 57 plasma lipids 57 pre menopausal 57 cerebrovascular diseases 57 serum prostate 57 Dietary fat 57 undergoing coronary angiography 57 CI #.#-#.# [001] 57 squamous histology 57 precancerous adenomas 57 urinary tract symptoms LUTS 57 cervical lesions 57 laryngeal cancers 57 bronchogenic carcinoma 57 Peripheral arterial disease 57 choroidal neovascularization CNV 57 mg BID dose 57 MGUS 57 platelet activation 57 recurrent atrial fibrillation 57 HMG CoA reductase inhibitory 57 μmol L 57 Triglyceride levels 57 Colorectal cancer incidence 57 oxycodone CR 57 atherothrombotic 57 prostate pancreatic 57 oropharyngeal 57 gastroesophageal 57 chronic HBV infection 57 grade cervical intraepithelial 57 recurrent ischemia 57 stable angina 57 Sleep disturbances 57 alanine transaminase ALT 57 metabolic syndrome clustering 57 venous thromboembolism 57 skeletal metastases 57 noncardiovascular mortality 57 micronuclei 57 Apolipoprotein B 57 oral bisphosphonate 57 hypertension diabetes mellitus 57 myocardial reperfusion 57 lumbar spine bone 57 p# mutations 57 stent stenosis 57 CYPHER Stent 57 CIN3 + 57 Myocardial infarction 57 selenium deficient 57 Univariate analysis 57 nonmelanoma skin cancer 57 proliferative retinopathy 57 urinary albumin 57 deep venous thrombosis 57 radiochemotherapy 57 hypervascular 57 Hepatocellular Carcinoma HCC 57 Sleep disordered breathing 57 #mmHg [002] 57 clinicopathological features 57 NATRECOR R 57 lymphomas leukemias 57 serum aminotransferase levels 57 untreated OSA 57 ovarian breast 57 fragility fractures 57 leptin deficiency 57 inhospital 57 thoracoscopic lobectomy 57 prostate walnut 57 Asymptomatic 57 pulmonary exacerbations 57 hypertension hypercholesterolemia 57 basal cell cancers 57 pelvic lymph nodes 57 electron beam computed tomography 57 confidence intervals CIs 57 pericardial effusion 57 trivial Klatsky 57 Oesophageal cancer 57 MACCE 57 impaired insulin secretion 57 artery stenosis 57 oxidized LDL 57 autoantibody positive 57 abnormal glucose tolerance 57 Subgroup analyzes 57 oophorectomy 57 microalbuminuria 57 adenomas 57 nonobstructive CAD 57 renal scarring 57 acute myocardial infarctions 57 intra abdominal abscess 57 metabolic disturbances 57 tibolone 57 fetal malformations 57 G allele 57 serum biomarker 57 bladder cancers 57 elevated depressive symptoms 57 cardio vascular disease 57 cirrhosis liver failure 57 invasive ductal carcinoma 57 recurrent miscarriage 57 flavanol rich foods 57 familial clustering 57 heme iron 57 upper gastrointestinal bleeding 57 alcoholic cirrhosis 57 myocardial infarctions MIs 57 Adenomas 57 elevated LDL 57 intermittent hypoxia 57 disease NAFLD 57 Zinc deficiency 57 postoperative infections 57 % CI #.#-#.# [006] 57 cardiometabolic risk 57 idiopathic pulmonary arterial hypertension 57 lymph node metastases 57 nonpregnant women 57 endometrial cancer 57 symptomatic intracerebral hemorrhage 57 androgen deprivation 57 coinfected patients 57 glycosylated hemoglobin levels 57 androgen excess 57 pheochromocytoma 57 lymph node involvement 57 esophagogastric 57 Avandia Actos 57 sleeve lobectomy 57 thyroid carcinoma 57 tibiofemoral 57 retroperitoneal 57 pyridostigmine 57 acute humoral rejection 57 glycated hemoglobin HbA1c 57 mmHg systolic 57 cancerdefine 57 #mmHg [001] 57 plasma adiponectin 57 serum IGF 57 alcoholic fatty liver 57 Thyroid nodules 57 recurrent acute pancreatitis 57 Lichen planus 57 bezafibrate 57 acute aortic dissection 57 testosterone supplementation 57 F FDG PET 57 pulmonary capillary wedge 57 neurosensory 57 gene polymorphism 57 CLA supplementation 57 thiazide diuretic 57 knee osteoarthritis OA